What’s actually ‘hot’ in the new era of post-hype TechBio | EU-Startups

▤ Summary

The article explains how TechBio investment has moved away from hype-driven, consumer-style healthcare software and toward deeper infrastructure. It argues that investors now favor high-fidelity data pipelines, explainable AI, and reproducible scientific systems over black-box tools. The piece highlights strong interest in platforms that clean and structure proprietary biological data for predictive modeling. It also points to compliance automation and biological resilience modeling as emerging areas of focus. Overall, the message is that foundational software infrastructure now matters more than flashy applications in TechBio.

▦ Linked Companies